pI: 5.6281 |
Length (AA): 608 |
MW (Da): 66928 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
271 | 406 | 1vr9 (A) | 1 | 119 | 19.00 | 0 | 1 | 0.43 | -1.24 |
257 | 404 | 5k23 (C) | 298 | 445 | 43.00 | 0 | 1 | 0.813221 | -0.49 |
257 | 428 | 4hg0 (A) | 53 | 213 | 29.00 | 0.000097 | 1 | 0.559995 | 0.4 |
258 | 411 | 4iys (A) | 431 | 584 | 45.00 | 0 | 1 | 0.851089 | -0.57 |
270 | 404 | 3hf7 (A) | 201 | 326 | 25.00 | 0 | 0.98 | 0.54664 | -0.75 |
448 | 580 | 3e97 (A) | 3 | 116 | 17.00 | 0 | 0.73 | 0.19935 | 0.05 |
474 | 588 | 5k8s (A) | 302 | 419 | 10.00 | 0.000092 | 0.18 | 0.279245 | -0.45 |
496 | 580 | 2byv (E) | 356 | 440 | 14.00 | 0.19 | 0.31 | 0.256903 | 0.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126632)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G14240 | CBS and DUF21 domain-containing protein |
Arabidopsis thaliana | AT2G14520 | CBS and transporter associated domain-containing protein |
Arabidopsis thaliana | AT4G33700 | hypothetical protein |
Arabidopsis thaliana | AT3G13070 | CBS domain and transporter associated domain-containing protein |
Arabidopsis thaliana | AT1G03270 | CBS domain-containing protein |
Arabidopsis thaliana | AT1G55930 | CBS and transporter associated domain-containing protein |
Arabidopsis thaliana | AT5G52790 | CBS domain-containing protein with a domain of unknown function (DUF21) |
Arabidopsis thaliana | AT1G47330 | hypothetical protein |
Arabidopsis thaliana | AT4G14230 | CBS domain-containing protein with a domain of unknown function (DUF21) |
Babesia bovis | BBOV_II006010 | conserved unknown domain containing membrane protein |
Brugia malayi | Bm1_41980 | ancient conserved domain protein 2 |
Brugia malayi | Bm1_32240 | ancient conserved domain protein 4 |
Brugia malayi | Bm1_52965 | ancient conserved domain protein 2 |
Candida albicans | CaO19.6979 | similar to S. cerevisiae MAM3 (YOL060C) needed for normal mitochondrial structure |
Caenorhabditis elegans | CELE_C33D12.2 | Protein C33D12.2 |
Caenorhabditis elegans | CELE_C52D10.12 | Protein C52D10.12 |
Caenorhabditis elegans | CELE_R04E5.2 | Protein R04E5.2 |
Cryptosporidium hominis | Chro.60221 | CBS domain multi-pass transmembrane protein |
Cryptosporidium hominis | Chro.30153 | hypothetical protein |
Cryptosporidium parvum | cgd3_1210 | hypothetical protein having a signal peptide, conserved region, and three or more transmembrane domains |
Cryptosporidium parvum | cgd6_1840 | cyclin M2-like membrane-associated protein with 4 transmembrane domains and 2 CBS domains |
Chlamydia trachomatis | CT_256 | hypothetical protein |
Chlamydia trachomatis | CT_423 | CBS domain-containing protein |
Chlamydia trachomatis | CT_257 | hypothetical protein |
Dictyostelium discoideum | DDB_G0279807 | hypothetical protein |
Drosophila melanogaster | Dmel_CG42595 | unextended |
Escherichia coli | b0658 | putative ion transport |
Escherichia coli | b4218 | UPF0053 family inner membrane protein |
Escherichia coli | b4461 | UPF0053 family inner membrane protein |
Echinococcus granulosus | EgrG_000779900 | metal transporter cnnm2 |
Echinococcus granulosus | EgrG_000828400 | metal transporter cnnm2 |
Echinococcus multilocularis | EmuJ_000779900 | metal transporter cnnm2 |
Echinococcus multilocularis | EmuJ_000828400 | metal transporter cnnm2 |
Giardia lamblia | GL50803_16803 | Hypothetical protein |
Homo sapiens | ENSG00000119946 | cyclin and CBS domain divalent metal cation transport mediator 1 |
Homo sapiens | ENSG00000148842 | cyclin and CBS domain divalent metal cation transport mediator 2 |
Homo sapiens | ENSG00000158158 | cyclin and CBS domain divalent metal cation transport mediator 4 |
Leishmania braziliensis | LbrM.20.2210 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_342480.1 | Domain of unknown function DUF21, putative |
Leishmania infantum | LinJ.34.2480 | hypothetical protein, conserved |
Leishmania major | LmjF.34.2650 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.33.2650 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05642 | hypothetical protein |
Loa Loa (eye worm) | LOAG_08918 | hypothetical protein |
Loa Loa (eye worm) | LOAG_06883 | hypothetical protein |
Loa Loa (eye worm) | LOAG_01980 | hypothetical protein |
Loa Loa (eye worm) | LOAG_09519 | hypothetical protein |
Mus musculus | ENSMUSG00000037408 | cyclin M4 |
Mus musculus | ENSMUSG00000025189 | cyclin M1 |
Mus musculus | ENSMUSG00000064105 | cyclin M2 |
Mycobacterium tuberculosis | Rv2366c | Probable conserved transmembrane protein |
Mycobacterium tuberculosis | Rv1842c | Conserved hypothetical membrane protein |
Mycobacterium tuberculosis | Rv1841c | Conserved hypothetical membrane protein |
Neospora caninum | NCLIV_001170 | CBS domain multi-pass transmembrane protein, putative |
Neospora caninum | NCLIV_011630 | hypothetical protein |
Oryza sativa | 4338701 | Os05g0395300 |
Oryza sativa | 4331466 | Os03g0125800 |
Oryza sativa | 4333362 | Os03g0593200 |
Onchocerca volvulus | OVOC6734 |
|
Onchocerca volvulus | OVOC3688 |
|
Onchocerca volvulus | OVOC10772 |
|
Onchocerca volvulus | OVOC1802 |
|
Onchocerca volvulus | OVOC12601 |
|
Plasmodium berghei | PBANKA_0832900 | protein MAM3, putative |
Plasmodium falciparum | PF3D7_0932100 | protein MAM3, putative |
Plasmodium knowlesi | PKNH_0730800 | protein MAM3, putative |
Plasmodium vivax | PVX_087105 | protein MAM3, putative |
Plasmodium yoelii | PY03208 | putative ancient conserved domain protein |
Plasmodium yoelii | PY03209 | hypothetical protein |
Saccharomyces cerevisiae | YOL060C | Mam3p |
Schistosoma japonicum | Sjp_0065700 | Metal transporter CNNM2, putative |
Schistosoma mansoni | Smp_134460 | ancient conserved domain protein 2 (cyclin m2) |
Schmidtea mediterranea | mk4.001979.05 | Unextended |
Schmidtea mediterranea | mk4.043110.00 | Putative annexin |
Schmidtea mediterranea | mk4.007949.02 | Unextended |
Schmidtea mediterranea | mk4.014316.00 | Unextended |
Schmidtea mediterranea | mk4.010239.00 | Unextended |
Schmidtea mediterranea | mk4.026767.00 | Putative annexin |
Schmidtea mediterranea | mk4.012313.00 | Unextended |
Schmidtea mediterranea | mk4.013234.00 | Unextended |
Trypanosoma brucei gambiense | Tbg972.4.1890 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.4.1970 | Domain of unknown function DUF21, putative |
Trypanosoma congolense | TcIL3000_4_1710 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.510877.90 | Domain of unknown function DUF21, putative |
Toxoplasma gondii | TGME49_211350 | CBS domain-containing protein |
Toxoplasma gondii | TGME49_307580 | CBS domain-containing protein |
Treponema pallidum | TP0028 | hemolysin |
Treponema pallidum | TP0649 | hemolysin (tlyC) |
Treponema pallidum | TP0027 | hemolysin |
Theileria parva | TP02_0556 | hypothetical protein |
Wolbachia endosymbiont of Brugia malayi | Wbm0809 | hemolysin |
Wolbachia endosymbiont of Brugia malayi | Wbm0070 | Mg2+/Co2+ transporter |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1871 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.4.1970 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.1970 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.1970 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.1970 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0658 | Escherichia coli | non-essential | goodall |
b4461 | Escherichia coli | non-essential | goodall |
b4218 | Escherichia coli | non-essential | goodall |
PBANKA_0832900 | Plasmodium berghei | Slow | plasmo |
TGME49_211350 | Toxoplasma gondii | Probably essential | sidik |
TGME49_307580 | Toxoplasma gondii | Probably essential | sidik |
TGME49_211350 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_307580 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1